-----begin privacy-enhanced message----- proc-type: 2001,mic-clear originator-name: webmaster@www.sec.gov originator-key-asymmetric: mfgwcgyevqgbaqicaf8dsgawrwjaw2snkk9avtbzyzmr6agjlwyk3xmzv3dtinen twsm7vrzladbmyqaionwg5sdw3p6oam5d3tdezxmm7z1t+b+twidaqab mic-info: rsa-md5,rsa, ub3rdcdg5f5z6krayhvjty0vcfqtvgjj1g2ym3y1+ul80k1uophswcz/blrrnnfp 3gir+vfxpiptlo+nubzjrg== 0001144204-07-060353.txt : 20071113 0001144204-07-060353.hdr.sgml : 20071112 20071113142524 accession number:		0001144204-07-060353 conformed submission type:	sc 13d public document count:		2 filed as of date:		20071113 date as of change:		20071113 subject company:	 	company data:	 		company conformed name:			joytoto usa, inc. 		central index key:			0001178377 		standard industrial classification:	services-business services, nec [7389] 		irs number:				954886472 		state of incorporation:			nv 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-79139 		film number:		071237006 	business address:	 		street 1:		3000 scott boulevard, suite 206 		city:			santa clara 		state:			ca 		zip:			95054 		business phone:		408 970-8050 	mail address:	 		street 1:		3000 scott boulevard, suite 206 		city:			santa clara 		state:			ca 		zip:			95054 	former company:	 		former conformed name:	biostem, inc. 		date of name change:	20051118 	former company:	 		former conformed name:	national parking systems, inc. 		date of name change:	20050110 	former company:	 		former conformed name:	cascade mountain mining co inc 		date of name change:	20030729 filed by:		 	company data:	 		company conformed name:			joytoto co., ltd 		central index key:			0001417981 		irs number:				000000000 	filing values: 		form type:		sc 13d 	business address:	 		street 1:		3fl sungwoo building 		street 2:		717-3 sooseo-dong, kangnam-gu 		city:			seoul 		state:			m5 		zip:			135-220 		business phone:		82-2-2194-5458 	mail address:	 		street 1:		3fl sungwoo building 		street 2:		717-3 sooseo-dong, kangnam-gu 		city:			seoul 		state:			m5 		zip:			135-220 sc 13d 1 v093819_sc13d.htm unassociated document &#160; &#160; &#160; &#160; omb approval united states omb number: 3235-0145 securities and exchange commission expires: february 28, 2009 &#160; washington, d.c. 20549 estimated average burden &#160; hours per response............14.5 schedule 13d under the securities exchange act of 1934 (amendment no._________)* joytoto usa, inc. (name of issuer) common stock (title of class of securities) 48122q 104 (cusip number) brian a. lebrecht, esq. the lebrecht group, aplc 9900 research drive irvine, ca 92618 (949) 635-1240 (name, address and telephone number of person authorized to receive notices and communications) october 31, 2007 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition that is the subject of this schedule 13d, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o note : schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see section 240.13d-7 for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of section 18 of the securities exchange act of 1934 (&#8220;act&#8221;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number. &#160; &#160; cusip no.&#160;&#160; &#160; 4822q 104 &#160; &#160; 1. names of reporting persons. i.r.s. identification nos. of above persons (entities only) &#160; joytoto co. ltd., a korean corporation &#160; &#160; 2. check the appropriate box if a member of a group (see instructions) &#160; &#160; (a)&#160;&#160;&#160; o &#160; &#160; &#160; (b)&#160;&#160;&#160; o &#160; &#160; &#160; 3. sec use only &#160; &#160; 4. source of funds (see instructions) &#160; oo &#160; &#160; 5. check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e)&#160;&#160; &#160;&#160;&#160; o &#160; &#160; 6. citizenship or place of organization &#160; republic of korea &#160; number of shares beneficially owned by each reporting person with 7. sole voting power &#160; 115,000,000 &#160; 8. shared voting power &#160; 0 &#160; 9. sole dispositive power &#160; 115,000,000 &#160; 10. shared dispositive power &#160; 0 &#160; &#160; 11. aggregate amount beneficially owned by each reporting person &#160; 115,000,000 &#160; &#160; 12. check if the aggregate amount in row (11) excludes certain shares (see instructions) &#160;&#160; o &#160; &#160; 13. percent of class represented by amount in row (11) &#160; 74.86% &#160; &#160; 14. type of reporting person (see instructions) &#160; co &#160; item 1. security and issuer common stock, .0001 par value joytoto usa, inc., 3000 scott boulevard, suite 206, santa clara, ca 95054 item 2. identity and background &#160; (a) name: this statement is filed on behalf of joytoto co. ltd., a korean corporation (&#8220;reporting person&#8221;). &#160; (b) residence or business address of the reporting person is: &#160; &#160; 3fl sungwoo bldg, 717-3 sooseo-dong, kangnam-gu &#160; &#160; seoul, korea 135-220 &#160; (c) principal occupation or employment: &#160; &#160; &#160; &#160; &#160; &#160; &#160; (d) during the last five years, the reporting person has not been convicted in a criminal proceeding. &#160; (e) during the last five years, the reporting person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding been subject to a judgment, decree or final order enjoining future violations or prohibiting or mandating activities subject to, federal or state securities law or finding any violation with respect to such law. item 3. source and amount of funds or other consideration the 115,000,000 shares of joytoto usa, inc., were acquired by reporting person pursuant to the terms of a stock exchange agreement dated october 12, 2007, under which the reporting person agreed to sell 100% of the outstanding common stock of joyon entertainment, inc., a delaware corporation, in exchange for the 115,000,000 shares. item 4. purpose of transaction the 115,000,000 shares of joytoto usa, inc., were acquired by reporting person pursuant to the terms of a stock exchange agreement dated october 12, 2007, under which the reporting person agreed to sell 100% of the outstanding common stock of joyon entertainment, inc., a delaware corporation, in exchange for the 115,000,000 shares. as a result of the transaction, joytoto usa, inc.&#8217;s primary business will in consumer electronics and video games and new officers and directors were appointed to manage the operations. item 5. interest in securities of the issuer &#160; (a) the reporting person now owns 115,000,000 shares of common stock of joytoto usa, inc., which equates to 74.86% of joytoto usa&#8217;s outstanding common stock. &#160; (b) as to the 115,000,000 shares, reporting person owns the following rights: &#160; &#160; sole voting power: 115,000,000 &#160; &#160; shared voting power: 0 &#160; &#160; sole dispositive power: 115,000,000 shared dispositive power: 0 &#160; (c) none. &#160; (d) none. &#160; (e) not applicable. item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer none. item 7. material to be filed as exhibits &#160; 10.1 stock exchange agreement by and between issuer, reporting person and joyon entertainment, inc., dated october 12, 2007. signature after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. november 9, 2007 date /s/ seong sam cho signature seong sam cho, chief executive officer &#160;&#160; name/title attention. intentional misstatements or omissions of fact constitute federal criminal violations (see 18 u.s.c. 1001). &#160; ex-10.1 2 v093819_ex10-1.htm unassociated document exhibit 10.1 stock exchange agreement this stock exchange agreement (&#8220;agreement&#8221;) between biostem, inc., a nevada corporation(&#8220;biostem&#8221;), joytoto co., ltd., a korean company (&#8220;joytoto&#8221;) and joyon entertainment co., ltd., a korean company (&#8220;joyon,&#8221; and together with joytoto, the &#8220;shareholders&#8221;), being the owners of record of all of the issued and outstanding stock of joyon entertainment, inc., a delaware corporation (&#8220;jei&#8221;), is entered into as of october 12, 2007 recitals a. &#160; biostem is a public company quoted on the nasdaq over-the-counter market (otcbb). b. &#160; the shareholders own all of the issued and outstanding shares of common stock of jei (the &#8220;jei stock&#8221;).&#160;&#160;jei owns 100% of the capital stock of joytoto america, inc. and joytoto technologies, inc. c. &#160; the shareholders have agreed to sell to biostem and biostem has agreed to purchase the jei stock from the shareholders in exchange for 115,000,000 common shares of biostem, pursuant to the terms and conditions set forth in this agreement. d. &#160; jei will become a wholly-owned subsidiary of biostem. in consideration of the mutual representations, warranties, covenants and agreements contained in this agreement, the parties agree as follows: &#160; 1.&#160; &#160;&#160;&#160; &#160; exchange of stock . (a) &#160; the shareholders agree to transfer to biostem, and biostem agrees to purchase from the shareholders, all of the shareholders' right, title and interest in their jei stock, representing 100% of the issued and outstanding stock of jei, free and clear of all mortgages, liens, pledges, security interests, restrictions, encumbrances, or adverse claims of any nature. &#160; (b) &#160; at the closing (as defined in section 2 below), upon surrender by the shareholders of the certificates evidencing the jei stock duly endorsed for transfer to biostem or accompanied by stock powers executed in blank by the shareholders, biostem will cause 115,000,000 shares of its common voting stock, par value $0.001 (the &#8220;biostem stock&#8221;) to be issued to the shareholders, in full satisfaction of any right or interest which each shareholder held in the jei stock.&#160;&#160;the biostem stock will be issued to the shareholders with a restrictive legend as required by applicable securities laws.&#160;&#160;as a result of the exchange of the jei stock in exchange for the biostem stock, jei will become a wholly-owned subsidiary of biostem. 2. &#160;&#160;&#160; &#160; closing . (a) &#160; the parties to this agreement will hold a closing (the &#8220;closing&#8221;) for the purpose of executing and exchanging all of the documents contemplated by this agreement and otherwise effecting the transactions contemplated by this agreement.&#160;&#160;the closing will be held as soon as possible but not later than october 15, 2007, in santa monica, california, unless another place or time is mutually agreed upon in writing by the parties.&#160;&#160;all proceedings to be taken and all documents to be executed and exchanged at the closing will be deemed to have been taken, delivered and executed simultaneously, and no proceeding will be deemed taken nor documents deemed executed or delivered until all have been taken, delivered and executed.&#160;&#160;if agreed to by the parties, the closing may take place through the exchange of documents by fax and/or express courier. (b) &#160; with the exception of any stock certificates which must be in their original form, any copy, fax, e-mail or other reliable reproduction of the writing or transmission required by this agreement or any signature required thereon may be used in lieu of an original writing or transmission or signature for any and all purposes for which the original could be used, provided that such copy, fax, e-mail or other reproduction is a complete reproduction of the entire original writing or transmission or original signature, and the originals are promptly delivered thereafter. (c) &#160; at closing, biostem shall have not more than fifty thousand dollars ($50,000) of accrued but unpaid accounts payable, and shall have no other liabilities. 3. &#160;&#160;&#160; &#160; representations and warranties of biostem . biostem represents and warrants as follows: &#160;(a) &#160; biostem is a corporation duly organized, validly existing, and in good standing under the laws of the state of nevada and is licensed or qualified as a foreign corporation in all states in which the nature of its business or the character or ownership of its properties makes such licensing or qualification necessary. &#160;(b) &#160; the only authorized capital stock of biostem, as of the closing date, shall consist of 310,000,000 shares of capital stock, of which 300,000,000 shares will be common stock, $0.001 par value per share, of which, based on the records of biostem's stock transfer agent, not more than 34,500,000 shares will be issued and outstanding as of the closing date, and 10,000,000 shares of preferred stock, of which none shall be outstanding as of the closing date.&#160;&#160;there shall be 21,000,000 warrants to purchase common stock at an exercise price of $0.10 per share, and 3,400,000 warrants to purchase common stock at an exercise price of $0.35 per share, outstanding as of the closing date.&#160;&#160;to the best knowledge of biostem, all issued and outstanding shares of biostem's common stock are fully paid and nonassessable. (c) &#160; biostem will have no subsidiaries as of the closing date. &#160; (d) &#160; execution of this agreement and performance by biostem hereunder has been or will be duly authorized by all requisite corporate action on the part of biostem, and this agreement constitutes a valid and binding obligation of biostem, and biostem's performance hereunder will not violate any provision of any charter, bylaw, indenture, mortgage, lease, or agreement, or any order, judgment, decree, or, to biostem's knowledge any law or regulation, to which any property of biostem is subject or by which biostem is bound. &#160;(e) &#160; biostem has full corporate power and authority to enter into this agreement and to carry out its obligations hereunder, and will deliver at the closing a copy of resolutions of its board of directors authorizing execution of this agreement by its officers and performance hereunder. &#160;(f) &#160; biostem has provided all financial statements and financial information in its possession as have been requested byte shareholders. (g) &#160; there is no litigation or proceeding pending, or to biostem's knowledge threatened, against or relating to biostem, its properties or business. (h) &#160; biostem is acquiring the jei stock to be transferred to it under this agreement for investment and not with a view to the sale or distribution thereof. 4. &#160;&#160;&#160; &#160; representations and warranties of the shareholders . the shareholders, jointly and severally, represent and warrant as follows: (a) &#160; jei is a corporation duly organized, validly existing, and in good standing under the laws of delaware and is licensed or qualified as a foreign corporation in all places in which the nature of its business or the character or ownership of its properties makes such licensing or qualification necessary. (b) &#160; there are no agreements purporting to restrict the transfer of the jei stock, nor any voting agreements, voting trusts or other arrangements restricting or affecting the voting of the jei stock.&#160;&#160;the jei stock held by the shareholders are duly and validly issued, fully paid and non-assessable, and issued in full compliance with all federal, state, and local laws, rules and regulations.&#160;&#160;there are no subscription rights, options, warrants, convertible securities, or other rights (contingent or otherwise) presently outstanding, for the purchase, acquisition, or sale of the capital stock of jei, or any securities convertible into or exchangeable for capital stock of jei or other securities of jei, from or by jei. (c) &#160; the shareholders have full right, power and authority to sell, transfer and deliver the jei stock, and upon delivery of the certificates therefore as contemplated in this agreement, the shareholders will transfer to biostem valid and marketable title to the jei stock, including all voting and other rights to the jei stock, free and clear of all pledges, liens, security interests, adverse claims, options, rights of any third party, or other encumbrances. (d) &#160; there is no litigation or proceeding pending, or to any shareholder's knowledge, threatened, against or relating to jei or to the jei stock. (e) &#160; jei has filed in correct form all tax returns of every nature required to be filed by it and has paid all taxes as shown on such returns and all assessments, fees and charges received by it to the extent that such taxes, assessments, fees and charges have become due.jei has also paid all taxes which do not require the filing of returns and which are required to be paid by it.to the extent that tax liabilities have accrued, but have not become payable, they have been adequately reflected as liabilities on the books of jei. (f) &#160; the jei shareholders have had the opportunity to perform all due diligence investigations of biostem and its business as they have deemed necessary or appropriate and to ask questions of biostem's officers and directors and have received satisfactory answers to all of their questions. the shareholders have had access to all documents and information about biostem and have reviewed sufficient information to allow them to evaluate the merits and risks of their exchange for the biostem stock. (g) &#160; the shareholders are acquiring the biostem stock for their own account (and not for the account of others) for investment and not with a view to the distribution therefor.the shareholders will not sell or otherwise dispose of the biostem stock without registration under the securities act of 1933, as amended, or an exemption therefrom, and the certificate or certificates representing the biostem stock will contain a legend to the foregoing effect. 5. &#160;&#160;&#160; &#160; additional covenants . (a) &#160; between the date of this agreement and the closing, the shareholders, with respect to jei, and biostem, with respect to itself, will, and will cause their respective representatives to: (i) afford the other party and its representatives access to their personnel, properties, contracts, books and records, and other documents and data, as reasonably requested by the other party; (ii) furnish the other party and its representatives with copies of all such contracts, books and records, and other existing documents and data as the other may reasonably request in connection with the transaction contemplated by this agreement; and (iii) furnish the other party and its representatives with such additional financial, operating, and other data and information as the other may reasonably request. 6. &#160;&#160;&#160; &#160; termination . this agreement may be terminated (1) by mutual consent in writing; (2) by either the shareholders or biostem if there has been material misrepresentation or material breach of any warranty or covenant by any other party that is not cured by october 15, 2007; or (3) by any of the shareholders or biostem if the closing has not taken place within 45 business days following execution of this agreement, unless adjourned to a later date by mutual consent in writing. 7. &#160;&#160;&#160; &#160; expenses . whether or not the closing is consummated, each of the parties will pay all of his, her, or its own legal and accounting fees and other expenses incurred in the preparation of this agreement and the performance of the terms and provisions of this agreement. &#160; &#160; &#160; 8. &#160;&#160;&#160; &#160; survival of representations and warranties . the representations and warranties of the shareholders and biostem set out in this agreement will survive the closing for a period of 30 days. 9. &#160;&#160;&#160; &#160; waiver . any failure on the part of either party hereto to comply with any of its obligations, agreements, or conditions hereunder may be waived in writing by the party to whom suchcompliance is owed. 10. &#160;&#160;&#160; &#160; brokers . each party agrees to indemnify and hold harmless the other party against any fee, loss, or expense arising out of claims by brokers or finders employed or alleged to have been employedby the indemnifying party. 11. &#160;&#160;&#160; &#160; general provisions . (a) &#160; this agreement will be governed by and under the laws of the state of nevada, usa without giving effect to conflicts of law principles.if any provision hereof is found invalid or unenforceable, that part will be amended to achieve as nearly as possible the same effect as the original provision and the remainder of this agreement will remain in full force and effect. (b) &#160; any dispute arising under or in any way related to this agreement will be resolved by binding arbitration under the commercial arbitration rules of the american arbitration association in santa monica, california. (c) &#160; in any adverse action, the parties will restrict themselves to claims for compensatory damages and/or securities issued or to be issued and no claims will be made by any party or affiliate for lost profits, punitive or multiple damages or any other consequential damages. (d) &#160; this agreement constitutes the entire agreement and final understanding of the parties with respect to the subject matter hereof and supersedes and terminates all prior and/or contemporaneous understandings and/or discussions between the parties, whether written or verbal, express or implied, relating in any way to the subject matter hereof.this agreement may not be altered, amended, modified or otherwise changed in any way except by a written agreement, signed by both parties. (e) &#160; this agreement will inure to the benefit of, and be binding upon, the parties hereto and their successors and assigns; provided, however, that any assignment by either party of its rights under this agreement without the written consent of the other party will be void. (f) &#160; the parties agree to take any further actions and to execute any further documents which may from time to time be necessary or appropriate to carry out the purposes of this agreement. (g) &#160; the headings of the sections, paragraphs and subparagraphs of this agreement are solely for convenience of reference and will not limit or otherwise affect the meaning of any of the terms or provisions of this agreement.the references in this agreement to sections, unless otherwise indicated, are references to sections of this agreement. (h) &#160; this agreement may be executed in counterparts, each one of which will constitute an original and all of which taken together will constitute one document.this agreement may be executed by delivery of a signed signature page by fax to the other parties hereto and such fax execution and delivery will be valid in all respects. &#160; &#160; &#160; biostem, inc. by: /s/ marc ebersole &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; marc ebersole chief executive officer joytoto co. ltd. by: /s/ seong sam cho &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; name: cho, seong sam title: chairman joyon entertainment co., ltd. by: /s/ seong yong cho &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; &#160;&#160;&#160; &#160; name: cho, seong yong title: chief executive officer -----end privacy-enhanced message----- 